Research @ UVA Engineering

Prof. Giri graduated from Chemical Engineering at Stanford University, working on the crystallization control of organic semiconductors for flexible electronic applications. His postdoctoral work focused on the use of microfluidics and continuous flow processing for pharmaceutical industry.

Donald Griffin improves clinical translation of acellular and cellular therapies through enhanced hydrogel-tissue integration, specifically focusing on the development of passive and active instructional microenvironments using microscale building blocks.

Kimberly Kelly uses computational methods and bioinformatics to develop more effective and less toxic cancer drugs through the identification of disease-relevant druggable targets, with a special emphasis on translation to the clinic and commercialization.

Born and raised and educated (all the way past Ph.D.) in Moscow, then USSR, what is now Russia. In 1991 moved to USA and worked in academic research and industrial positions. Research interests are in the area of chemistry applications in biomedical research.

Kelsey Kubelick leverages light, sound, nanoconstruct design and cellular engineering strategies to develop advanced theranostic imaging platforms. With a special interest in ultrasound and photoacoustics, her lab creates imaging tools that play a critical role in informing, guiding and enhancing therapies across a range of biomedical applications.

Kyle Lampe is an Associate Professor in the Department of Chemical Engineering at the University of Virginia, and by courtesy, Biomedical Engineering and Neuroscience.

Work in the Lazzara Lab employs a combination of experimental and computational methods to study problems in cell signaling, the complex biochemical process cells use to make decisions.

Kristen Naegle uses data- and computational-driven approaches to predict, and experimental approaches to test, the regulation and function of tyrosine phosphorylation in complex networks.

For the past 35+ years, Blair has been a pharmaceutical manufacturing, quality, and development executive where he has had the opportunity to work globally and drive twelve new chemical/biological and biosimilar products through development and into sustained commercial production.